|
|
Cells Engineered to Reduce Atherosclerosis
|
| Link ID |
8439 |
| Title |
Cells Engineered to Reduce Atherosclerosis |
| Url |
http://www.medscape.com/viewarticle/580088?src=rss |
| Description |
Descendants of hematopoietic progenitor cells that were genetically engineered to express apolipoprotein AI (apoAI) counter the accumulation of cholesterol on artery walls, according to a study in mice by researchers from Vanderbilt University reported in the August issue of Arteriosclerosis, Thrombosis, and Vascular Biology. ApoAI is the major protein component of high-density lipoprotein. Reuters Health Information |
| Category |
Articles > Cardiology |
| Keywords |
|
| Date |
Sep 6, 2008 |
| Contact Name |
|
| Email |
|
Write a Review
Add to My Favorite
Refer it to Friend
Report Broken Link
|
|
Other links at Articles > Cardiology |
| 5. |
New Drug Algorithms, New Drug Approvals, New Drugs
|
|
|
Stepped-care approach or national guidelines? New beta-blocker? New approval for an ARB? Or what about an ARB plus endothelin receptor antagonist combination pill? All in the news this month.
Medscape Cardiology
|
|
|